Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Jabbour, Serge
Item TypeName
Concept Diabetes Mellitus
Concept Diabetes Mellitus, Type 1
Concept Diabetes Mellitus, Type 2
Academic Article Advantages of extended-release metformin in patients with type 2 diabetes mellitus.
Academic Article Management of diabetes mellitus in the elderly.
Academic Article Exenatide once weekly in type 2 diabetes mellitus.
Academic Article Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor dapagliflozin.
Academic Article Collaboration designed to increase translation of diabetes research outcomes into clinical practice.
Academic Article Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
Academic Article Diabetes knowledge: are resident physicians and nurses adequately prepared to manage diabetes?
Academic Article A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
Academic Article SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem.
Academic Article Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.
Academic Article Comment and response to: dapagliflozin - do we need it registered for type 2 diabetes?
Academic Article Incidence and severity of pancreatogenic diabetes after pancreatic resection.
Academic Article Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.
Academic Article Durability of response to dapagliflozin: a review of long-term efficacy and safety.
Academic Article Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.
Academic Article Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Academic Article Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION-8 randomized controlled trial.
Academic Article Evaluation of an Ongoing Diabetes Group Medical Visit in a Family Medicine Practice.
Academic Article Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study.
Academic Article Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: An analysis of the NHANES surveys from 1999 to 2014.
Academic Article Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.
Academic Article Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION-8 study.
Academic Article Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
Academic Article Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial.
Academic Article Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.
Academic Article Hormone-substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active-controlled DURATION-8 study.
Academic Article Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial.
Academic Article Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes.
Academic Article SGLT2 inhibitors.
Academic Article Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52?weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3 trial.
Academic Article Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial.
Academic Article Assessing the impact of medically tailored meals and medical nutrition therapy on type 2 diabetes: Protocol for Project MiNT.
Academic Article Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice.
Academic Article Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis.
Academic Article Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database Analysis.
Academic Article Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine.
Academic Article Switching to Tirzepatide 5?mg From Glucagon-Like Peptide-1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of Treatment.
Academic Article Primary care physicians and insulin initiation: multiple barriers, lack of knowledge or both?
Academic Article Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes.
Academic Article Type 2 diabetes and HbA1c goal: time for individualised therapy.
Academic Article Dapagliflozin in type 2 diabetes: effectiveness across the spectrum of disease and over time.
Academic Article Uncontrolled diabetes mellitus.
Search Criteria
  • Diabetes Mellitus